Explore Active Clinical Studies
Browse our current and upcoming Phase II - IV clinical research studies. Select a study to review details and submit an online pre-screening questionnaire to check your initial eligibility.
LAM-001
Inhaled Therapeutics for Lymphangioleiomyomatosis (LAM)
Evaluate the safety, tolerability, and pharmacokinetics of inhaled LAM-001 in patients diagnosed with LAM or progressive pulmonary fibrosis.
COPD-002
Bronchodilator Therapy Optimization Study
A randomized, double-blind study testing the efficacy of a novel combination inhaler treatment for patients with moderate-to-severe COPD.
GUT-301
Microbiome Restoration Therapy in IBD
Investigating the impact of microbiome-targeted capsules (GUT-301) on mucosal healing and inflammation in patients with active IBD.
NEPH-402
Cardiovascular Risk Management in CKD Patients
Observational safety study monitoring long-term cardiovascular profiles in patients receiving novel renal-protective therapeutic agents.
Not sure which trial fits you?
You can fill out our general clinical trial pre-screening registry form. Our clinical coordinators will review your health profile and contact you as soon as a trial matching your history becomes available.
General Volunteer Form